PDMR dealing, Admission and Total Voting Rights
Source: RNS
ANIMALCARE GROUP PLC
("Animalcare" or the "Company")
Option Exercise, PDMR Dealing, Admission and Total Voting Rights
16 May 2024. Animalcare Group plc (AIM: ANCR), the international animal health business, announces that on 15 May 2024, options over a total of 221,857 ordinary shares of 20p each in the Company ("Ordinary Shares") held under the Company's Long Term Incentive Plan (LTIP) were exercised by Jennifer Winter, Chief Executive Officer, and Chris Brewster, Chief Financial Officer, both PDMRs.
Application has been made to the London Stock Exchange for the admission of 221,857 Ordinary Shares ("New Ordinary Shares") to trading on AIM ("Admission") and it is expected that Admission of the New Ordinary Shares will become effective and trading will commence at 8.00am on 22 May 2024.
Subsequent to the exercise of options, Jennifer Winter sold 95,220 Ordinary Shares at a price of £2.25 per Ordinary Share to cover the income tax and National Insurance liability resulting from the exercise of the above-mentioned options and Chris Brewster sold 65,245 Ordinary Shares at a price of £2.25 per Ordinary Share.
Following the completion of the exercise and sale, the aggregate shareholdings of Jennifer Winter and Chris Brewster will be:
|
Name |
Aggregate shareholding (Ordinary Shares) |
Percentage of total voting rights |
|
Jennifer Winter |
68,392 |
0.11% |
|
Chris Brewster |
280,513 |
0.46% |
The New Ordinary Shares, when issued, will be fully paid and will rank pari-passu in all respects with the existing ordinary shares, including the right to receive all dividends and other distributions declared, made or paid after the date of issue. The issue and allotment of the New Ordinary Shares will be within the Company's existing authorities.
Total Voting Rights
Subsequent to Admission, there will be 60,374,268 Ordinary Shares in issue with voting rights. No shares are held in treasury. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
The notifications below, made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation, provide additional detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMR) and persons closely associated with them (PCA)
ANNEX
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Jennifer Winter, Chief Executive Officer |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
See 1(a) above - Ms Winter is classified as a PDMR of the Company |
||||
|
b) |
Initial notification /Amendment |
Initial Notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Animalcare Group plc |
||||
|
b) |
LEI |
213800A7XPQ528RMCC72 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 20p per shares |
||||
|
b) |
Identification code |
GB0032350695 |
||||
|
c) |
Nature of the transaction(s) |
Acquisition of share on exercise of options under the Animalcare Group plc Long Term Incentive Plan ("LTIP") |
||||
|
d) |
Price(s) and volume(s) |
|
||||
|
e) |
Aggregated information
- Aggregated volume
- Price |
N/A |
||||
|
f) |
Date of the transaction |
15 May 2024 |
||||
|
g) |
Place of the transaction |
Outside a trading venue |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 20p per share |
||||
|
b) |
Identification code |
GB0032350695 |
||||
|
c) |
Nature of the transaction(s) |
Disposal of ordinary shares of 20p per share to cover tax and national insurance liabilities resulting from abovementioned exercise of options |
||||
|
d) |
Price(s) and volume(s) |
|
||||
|
e) |
Aggregated information
- Aggregated volume
- Price |
N/A |
||||
|
f) |
Date of the transaction |
15 May 2024 |
||||
|
g) |
Place of the transaction |
Outside a trading venue |
||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Chris Brewster, Chief Financial Officer |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
See 1(a) above - Mr Brewster is classified as a PDMR of the Company |
||||
|
b) |
Initial notification /Amendment |
Initial Notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Animalcare Group plc |
||||
|
b) |
LEI |
213800A7XPQ528RMCC72 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 20p per share |
||||
|
b) |
Identification code |
GB0032350695 |
||||
|
c) |
Nature of the transaction(s) |
Acquisition of share on exercise of options under the Animalcare Group plc Long Term Incentive Plan ("LTIP") [and disposal of ordinary shares] |
||||
|
d) |
Price(s) and volume(s) |
|
||||
|
e) |
Aggregated information
- Aggregated volume
- Price |
N/A |
||||
|
f) |
Date of the transaction |
15 May 2024 |
||||
|
g) |
Place of the transaction |
Outside a trading venue |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 20p per share |
||||
|
b) |
Identification code |
GB0032350695 |
||||
|
c) |
Nature of the transaction(s) |
Disposal of ordinary shares |
||||
|
d) |
Price(s) and volume(s) |
|
||||
|
e) |
Aggregated information - Aggregated volume - Price |
N/A |
||||
|
f) |
Date of the transaction |
15 May 2024 |
||||
|
g) |
Place of the transaction |
Outside a trading venue |
||||
Enquiries:
|
Animalcare Group plc |
|
|
Chris Brewster, Chief Financial Officer and Company Secretary |
+44 (0)1904 487 687 communications@animalcaregroup.com
|
|
Stifel Nicolaus Europe Limited (Nominated Adviser & Joint Broker) |
+44 (0)20 7710 7600 |
|
Ben Maddison Nick Adams Nicholas Harland Francis North
|
|
|
Panmure Gordon (Joint Broker) |
+44 (0)20 7886 2500 |
|
Corporate Finance Freddy Crossley/Emma Earl Corporate Broking Rupert Dearden
|
|
About Animalcare
Animalcare Group plc is a UK AIM-listed international development-focused veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
For more information, please visit www.animalcaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
